CT3 System for Consistent Gelatin Analysis Available From Brookfield
July 14, 2011
Middleboro, MA – Brookfield Engineering laboratories now offers a complete system for performing the “Gelatin Bloom Strength Test.” This system includes Brookfield’s enhanced CT3 Texture Analyzer for measuring bloom strength, two baths and one refrigeration unit for gelatin preparation. Customers can now get the complete Gelatin Bloom Strength Test system and an industry approved glass [...]
Illumina Selected as a Preferred Service Provider for Cancer Research UK
July 14, 2011
SAN DIEGO - Illumina, Inc. (NASDAQ:ILMN) today announced that the company has been selected as a preferred service provider for Cancer Research UK, the world's leading cancer charity. Illumina will provide a range of services, beginning with whole human genome sequencing, in support of the International Cancer Genome Consortium. The consortium is seeking to obtain [...]
Advanced Photonix, Inc. Announces Phase III T-Ray 4000(R) System Sale
July 14, 2011
ANN ARBOR, Mich. - Advanced Photonix, Inc.® (NYSE Amex: API) today announced that the Naval Undersea Warfare Center (NUWC) purchased a T-Ray 4000® from its wholly-owned subsidiary, Picometrix, LLC, to be used for research and testing applications that support their mission. The purchase was made via a Phase III contract which is a continuation from [...]
Proteom Sciences and Buck Institute to Develop Biomarker Tests to Improve Breast Cancer Treatment
July 14, 2011
London, UK & Novato, California; Proteome Sciences plc (“Proteome”) a global leader in biomarkers will collaborate with Buck Institute for Research on Aging (“Buck”) to develop personalized molecular tests for estrogen receptor alpha (ERa) aimed at improving outcomes in breast cancer. Under the agreement, Proteome will support development of clinical mass spectrometry assays measuring molecular [...]
AMSBIO Moves to Support the Glycobiology Research Community
July 14, 2011
AMSBIO has announced a package of initiatives to support the Glycobiology research community following the recent announcement by Seikagaku Corporation that they plan to discontinue their research reagents and glycobiology biochemicals business as of September 30th 2011. As a specialist in high purity reagents for glycobiology and glycoanalysis for over 20 years - AMSBIO has [...]
Agilent Technologies Offers Grants for Research in Integrated Biology
July 14, 2011
SANTA CLARA Calif. - Agilent Technologies Inc. (NYSE: A) today announced that it is accepting entries for two systems biology research grants, both intended to spur development of open source data-integration tools. Each grant will provide $75,000 to a single academic or non-profit research lab in 2011. Grant 1: Validating Protein Pathway Information - Integrating [...]
July 14, 2011
SUNNYVALE, Calif. - Molecular Devices, LLC, a leader in bioanalytical systems for drug discovery & development, life science research, and bioassay/test development, today announced that the American Association for Laboratory Accreditation (A2LA) has accredited the Laboratory Quality System under ISO/IEC 17025 for validation plate calibration and re-calibration processes. Molecular Devices is one of the first [...]
July 14, 2011
Toronto, Canada and Sunnyvale CA, USA – DVS Sciences, Inc., a privately held innovator and manufacturer of highly multi-parameter single-cell analyzers and reagents for biological research and clinical applications, announced today that it has secured US $14.6 million in a Series A venture financing round. The proceeds will be used to accelerate the company’s commercial [...]
Pall Corp. Announces Expansion Plans in Brazil
July 14, 2011
PORT WASHINGTON, N.Y. - Pall Corporation (NYSE:PLL), a global leader in filtration, separation and purification, announced today that it has signed a definitive agreement to acquire its long-time Brazilian distribution partner, Engefiltro. The acquisition will strengthen Pall’s capabilities to support customers in the fast-growing Latin American market. The transaction is expected to be completed by [...]
Life Technologies Develops Potent Drug Delivery Technology for Therapeutics Market
July 14, 2011
CARLSBAD, Calif. - Life Technologies Corporation today announced that it has developed new drug delivery technology specially designed for therapeutic applications that is 100-fold more potent than previous formulations. The technology is available for licensing as part of a new out-licensing program. Scientists at Life Technologies have developed the novel proprietary siRNA delivery reagents by [...]

